drugset / Trial / NCT00342849

Treatment of Lead-Exposed Children Trial

NCT00342849

RandomizedParallel-groupTriple-blindTreatment

Summary

The Treatment of Lead-Exposed Children (TLC) clinical trial compared the effect of lead chelation with succimer to placebo therapy. TLC was a randomized, double-blind, placebo-controlled clinical trial with sites in Cincinnati and Columbus, Ohio, Philadelphia, Pennsylvania, Baltimore, Maryland and Newark, New Jersey. The study was designed to test outcomes in IQ, neuropsychological function, behavior, physical growth and blood pressure three years after initiation of treatment. Enrollment was conducted between 1994 and 1997, with completion of the initial three-year follow-up in 2000.

Timeline

Start
1994-07-15
Primary completion
2007-08-29
Completion
2015-06-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Succimer Small molecule Oral

Indications